Go Back
Go Back

Day 1

01 Welcome & Opening remarks

01 Welcome & Opening remarks

02 J. Marquardt - Molecular Carcinogenesis

02 J. Marquardt - Molecular Carcinogenesis

03 D. Kountouras - High Risk population/ Prevention/Risk Reduction /Early Diagnosis

03 D. Kountouras - High Risk population/ Prevention/Risk Red...

04 K. Pavlou - HCC or CCA? Can the radiologist or pathologist give a definite answer?

04 K. Pavlou - HCC or CCA? Can the radiologist or pathologis...

05 D. Dimitroulopoulos - Greek perspective

05 D. Dimitroulopoulos - Greek perspective

06 G. Tzimas  - Liver surgery in early liver cancer & in relapse

06 G. Tzimas - Liver surgery in early liver cancer & in rela...

07 C. Dimosthenopoulos - Nutritional Therapy for HCC

07 C. Dimosthenopoulos - Nutritional Therapy for HCC

08 D. Tzavoulis - Inoperable recurrence: TACE/ Radioembolism

08 D. Tzavoulis - Inoperable recurrence: TACE/ Radioembolism

09 G. Kritselis - Stereotactic radiotherapy in liver tumors

09 G. Kritselis - Stereotactic radiotherapy in liver tumors

10 T. Tegos - Greek perspective

10 T. Tegos - Greek perspective

11 F. Foerster - German perspective

11 F. Foerster - German perspective

12 A. Kontos - OncoSil: A breakthrough for inoperable pancreatic cancer.

12 A. Kontos - OncoSil: A breakthrough for inoperable pancre...

13 A. Angelis - Liver Transplantation & Hepatocellular Carcinoma. Where do we stand?

13 A. Angelis - Liver Transplantation & Hepatocellular Carci...

14 A. Fotopoulos - Overview of European research programs for cancer screening & prevention. The case of ONCOSCREEN

14 A. Fotopoulos - Overview of European research programs fo...

15 G. Lypas - Intrahepatic vs Extrahepatic vs Gallbladder: clinical & molecular features

15 G. Lypas - Intrahepatic vs Extrahepatic vs Gallbladder: c...